MARSHALL WACE, LLP - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 204 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 16.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$2,407,839
+170.5%
64,209
+102.9%
0.01%
+150.0%
Q3 2022$890,000
-10.0%
31,638
+11.2%
0.00%0.0%
Q2 2022$989,000
+58.2%
28,441
+63.3%
0.00%
+100.0%
Q1 2022$625,000
-79.0%
17,417
-86.8%
0.00%
-95.2%
Q2 2020$2,970,000
-33.7%
132,228
-56.2%
0.02%
-53.3%
Q1 2020$4,481,000
-21.0%
301,910
+2.7%
0.04%
+15.4%
Q4 2019$5,673,000
-30.8%
294,064
-28.8%
0.04%
-39.1%
Q3 2019$8,196,000413,2930.06%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders